Insider Trading activities at Supernus Pharmaceuticals, Inc. (SUPN)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Supernus Pharmaceuticals, Inc. (SUPN) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Supernus Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1356576.

Total stock buying since 2014: $189,979.
Total stock sales since 2014: $97,750,946.
Total stock option exercises since 2014: $28,951,058.


 1   2 
19 insiders reported insider trading activities at Supernus Pharmaceuticals, Inc. (SUPN):
Insider trading activities of Mottola Frank
Insider trading activities of Bryan Jones W.
Insider trading activities of Barris Peter J
Insider trading activities of Vaughn Victor
Insider trading activities of Schwabe Stefan K.f.
Insider trading activities of Rubin Jonathan
Insider trading activities of Khattar Jack A.
Insider trading activities of Hudson Frederick M.
Insider trading activities of Sandell Scott D
Insider trading activities of Gemayel Georges
Insider trading activities of Newhall Charles W Iii
Insider trading activities of Sensenig Bethany
Insider trading activities of Patrick Gregory S
Insider trading activities of Baskett Forest
Insider trading activities of Dec Timothy C
Insider trading activities of Siebert John M
Insider trading activities of Martin Tami Tillotson
Insider trading activities of Bhatt Padmanabh P.
Insider trading activities of Barrett M James

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Supernus Pharmaceuticals, Inc. (SUPN).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 494,383 $22,548,685 776,177 $12,548,829
2024 0 $0 297,095 $10,427,687 352,027 $4,104,183
2023 0 $0 50,662 $1,784,325 193,379 $735,394
2022 0 $0 124,099 $4,044,818 265,433 $2,325,796
2021 0 $0 6,250 $193,640 21,250 $275,824
2020 0 $0 155,920 $3,486,419 163,750 $1,873,267
2019 7,200 $189,979 20,000 $830,660 40,000 $365,200
2018 0 $0 452,850 $22,018,182 481,529 $4,358,263
2017 0 $0 267,418 $11,106,593 225,000 $2,072,599
2016 0 $0 36,157 $631,924 0 $0
2015 0 $0 1,275,199 $20,678,013 80,291 $282,426
2014 0 $0 0 $0 2,188 $9,277

Table 2. Monthly summary of insider trading at Supernus Pharmaceuticals, Inc. (SUPN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-11 0 $0 0 $0 15,000 $194,700
2025-10 0 $0 126,977 $6,356,321 178,889 $3,531,095
2025-09 0 $0 131,823 $6,158,811 188,323 $3,863,632
2025-08 0 $0 221,906 $9,491,349 276,500 $4,399,276
2025-03 0 $0 0 $0 80,065 $0
2025-02 0 $0 10,404 $412,528 14,127 $280,613
2025-01 0 $0 3,273 $129,676 23,273 $279,513
2024-12 0 $0 21,495 $788,436 21,495 $529,744
2024-11 0 $0 155,209 $5,632,020 155,787 $1,447,469
2024-09 0 $0 13,886 $435,048 31,000 $114,600
2024-08 0 $0 0 $0 1,250 $0
2024-03 0 $0 93,505 $3,197,853 93,505 $1,892,800
2024-02 0 $0 5,000 $151,050 40,990 $45,650
2024-01 0 $0 8,000 $223,280 8,000 $73,920
2023-12 0 $0 0 $0 25,600 $0
2023-11 0 $0 12,703 $360,399 16,914 $156,284
2023-10 0 $0 0 $0 4,000 $0
2023-09 0 $0 0 $0 37,500 $0
2023-08 0 $0 13,235 $421,414 8,100 $194,319
2023-05 0 $0 0 $0 33,500 $0
2023-03 0 $0 4,780 $172,022 21,500 $0
2023-02 0 $0 14,032 $590,094 27,843 $223,157
2023-01 0 $0 5,912 $240,396 18,422 $161,634
2022-12 0 $0 0 $0 8,722 $68,903

Table 3. Detailed insider trading at Supernus Pharmaceuticals, Inc. (SUPN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-11-21 Newhall Charles W Iii Option Ex 15,000 12.98 194,700
2025-10-09 Khattar Jack A. (President, CEO) Sale 59,900 51.01 3,055,199
2025-10-09 Khattar Jack A. (President, CEO) Option Ex 81,250 25.30 2,055,625
2025-10-09 Newhall Charles W Iii Sale 25,000 51.14 1,278,500
2025-10-02 Khattar Jack A. (President, CEO) Sale 1,904 48.06 91,506
2025-10-02 Khattar Jack A. (President, CEO) Option Ex 41,587 12.65 57,355
2025-10-01 Khattar Jack A. (President, CEO) Sale 40,173 48.07 1,931,116
2025-10-01 Khattar Jack A. (President, CEO) Option Ex 53,785 25.30 1,360,760
2025-09-30 Khattar Jack A. (President, CEO) Sale 8,588 48.25 414,371
2025-09-30 Khattar Jack A. (President, CEO) Option Ex 11,510 25.30 291,203
2025-09-29 Khattar Jack A. (President, CEO) Sale 10,235 48.02 491,484
2025-09-29 Khattar Jack A. (President, CEO) Option Ex 13,688 25.30 346,306
2025-09-25 Rubin Jonathan (SVP, Chief Medical Officer) Option Ex 1,875 .00 0
2025-09-23 Khattar Jack A. (President, CEO) Sale 29,513 47.23 1,393,898
2025-09-23 Khattar Jack A. (President, CEO) Option Ex 47,940 12.98 622,261
2025-09-22 Khattar Jack A. (President, CEO) Sale 16,587 47.02 779,920
2025-09-22 Khattar Jack A. (President, CEO) Option Ex 27,060 12.98 351,238
2025-09-12 Mottola Frank (SVP, Chief Tech. Ops. Officer) Sale 5,000 45.87 229,350
2025-09-12 Mottola Frank (SVP, Chief Tech. Ops. Officer) Option Ex 5,000 39.40 197,000
2025-09-08 Khattar Jack A. (President, CEO) Sale 6,322 46.29 292,645
2025-09-08 Khattar Jack A. (President, CEO) Option Ex 8,074 25.30 204,272
2025-09-05 Khattar Jack A. (President, CEO) Sale 55,578 46.01 2,557,143
2025-09-05 Khattar Jack A. (President, CEO) Option Ex 73,176 25.30 1,851,352
2025-08-28 Khattar Jack A. (President, CEO) Sale 24,150 45.12 1,089,648
2025-08-28 Khattar Jack A. (President, CEO) Option Ex 38,779 12.98 503,351
2025-08-27 Khattar Jack A. (President, CEO) Sale 10,650 45.05 479,782
2025-08-27 Khattar Jack A. (President, CEO) Option Ex 17,195 12.98 223,191
2025-08-27 Newhall Charles W Iii Sale 3,588 45.01 161,495
2025-08-25 Mottola Frank (SVP, Quality, GMP, Ops, IT) Sale 14,000 44.51 623,140
2025-08-25 Mottola Frank (SVP, Quality, GMP, Ops, IT) Option Ex 14,000 12.98 181,720
2025-08-25 Khattar Jack A. (President, CEO) Sale 1,000 45.00 45,000
2025-08-25 Khattar Jack A. (President, CEO) Option Ex 1,611 12.98 20,910
2025-08-25 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 1,250 .00 0
2025-08-25 Newhall Charles W Iii Sale 1,000 45.00 45,000
2025-08-22 Khattar Jack A. (President, CEO) Sale 1,500 45.00 67,500
2025-08-22 Khattar Jack A. (President, CEO) Option Ex 2,415 12.98 31,346
2025-08-22 Dec Timothy C (Senior Vice-President & CFO) Sale 11,780 44.49 524,092
2025-08-22 Newhall Charles W Iii Sale 1,412 45.00 63,540
2025-08-14 Sensenig Bethany Sale 5,369 42.25 226,840
2025-08-14 Hudson Frederick M. Sale 7,457 42.26 315,132
2025-08-06 Khattar Jack A. (President, CEO) Sale 140,000 41.79 5,850,180
2025-08-06 Khattar Jack A. (President, CEO) Option Ex 201,250 17.09 3,438,758
2025-03-10 Khattar Jack A. (President, CEO) Option Ex 35,000 .00 0
2025-03-10 Dec Timothy C (Senior Vice-President & CFO) Option Ex 3,800 .00 0
2025-03-07 Mottola Frank (SVP, Quality, GMP, Ops, IT) Option Ex 2,625 .00 0
2025-03-07 Khattar Jack A. (President, CEO) Option Ex 38,640 .00 0
2025-02-21 Rubin Jonathan (SVP, Chief Medical Officer) Sale 927 39.15 36,292
2025-02-21 Rubin Jonathan (SVP, Chief Medical Officer) Option Ex 1,875 .00 0
2025-02-21 Mottola Frank (SVP, Quality, GMP, Ops, IT) Option Ex 1,125 .00 0
2025-02-21 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 1,650 .00 0
2025-02-04 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 9,477 39.70 376,236
2025-02-04 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 9,477 29.61 280,613
2025-01-28 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 700 39.62 27,734
2025-01-28 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 700 29.61 20,727
2025-01-27 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 2,573 39.62 101,942
2025-01-27 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 2,573 29.61 76,186
2025-01-22 Hudson Frederick M. Option Ex 20,000 9.13 182,600
2024-12-03 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 21,495 36.68 788,436
2024-12-03 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 21,495 24.64 529,744
2024-11-11 Newhall Charles W Iii Sale 10,700 36.24 387,768
2024-11-11 Newhall Charles W Iii Option Ex 20,000 9.13 182,600
2024-11-08 Khattar Jack A. (President, CEO) Sale 125,000 36.29 4,536,250
2024-11-08 Khattar Jack A. (President, CEO) Option Ex 125,000 9.13 1,141,250
2024-11-08 Hudson Frederick M. Sale 8,722 36.28 316,434
2024-11-08 Gemayel Georges Sale 10,787 36.30 391,568
2024-11-08 Gemayel Georges Option Ex 10,787 11.46 123,619
2024-09-13 Gemayel Georges Sale 13,886 31.33 435,048
2024-09-13 Gemayel Georges Option Ex 10,000 11.46 114,600
2024-09-03 Khattar Jack A. (President, CEO) Option Ex 21,000 .00 0
2024-08-20 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 1,250 .00 0
2024-03-21 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 14,491 35.31 511,677
2024-03-21 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 14,491 25.30 366,622
2024-03-20 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 400 35.31 14,124
2024-03-20 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 400 25.30 10,120
2024-03-19 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 12,364 35.31 436,572
2024-03-19 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 12,364 25.30 312,809
2024-03-13 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 62,366 33.79 2,107,347
2024-03-13 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 62,366 18.48 1,152,835
2024-03-12 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 3,884 32.99 128,133
2024-03-12 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 3,884 12.98 50,414
2024-02-28 Mottola Frank (SVP, Quality, GMP, Ops, IT) Option Ex 990 .00 0
2024-02-28 Khattar Jack A. (President, CEO) Option Ex 35,000 .00 0
2024-02-26 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 5,000 30.21 151,050
2024-02-26 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 5,000 9.13 45,650
2024-01-10 Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) Sale 8,000 27.91 223,280
2024-01-10 Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) Option Ex 8,000 9.24 73,920
2023-12-22 Rubin Jonathan (Sr. VP, Chief Medical Officer) Option Ex 600 .00 0
2023-12-22 Khattar Jack A. (President, CEO) Option Ex 25,000 .00 0
2023-11-16 Newhall Charles W Iii Sale 2,500 28.01 70,025
2023-11-16 Newhall Charles W Iii Option Ex 7,457 9.24 68,902
2023-11-15 Hudson Frederick M. Sale 9,093 28.50 259,150
2023-11-15 Hudson Frederick M. Option Ex 7,457 9.24 68,902
2023-11-14 Mottola Frank (SVP, Quality, GMP, Ops, IT) Sale 1,110 28.13 31,224
2023-11-14 Mottola Frank (SVP, Quality, GMP, Ops, IT) Option Ex 2,000 9.24 18,480
2023-10-13 Dec Timothy C (Senior Vice-President & CFO) Option Ex 4,000 .00 0
2023-09-07 Khattar Jack A. (President, CEO) Option Ex 35,000 .00 0
2023-09-07 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 2,500 .00 0
2023-08-30 Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) Sale 8,100 32.00 259,200
2023-08-30 Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) Option Ex 8,100 23.99 194,319
2023-08-25 Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) Sale 5,135 31.59 162,214
2023-05-11 Khattar Jack A. (President, CEO) Option Ex 31,250 .00 0
2023-05-11 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 750 .00 0
2023-05-11 Dec Timothy C (Senior Vice-President & CFO) Option Ex 1,500 .00 0
2023-03-14 Mottola Frank (Sr VP, Quality, GMP Oper. & IT) Sale 4,780 35.99 172,022
2023-03-14 Khattar Jack A. (President, CEO) Option Ex 20,000 .00 0
2023-03-14 Dec Timothy C (Senior Vice-President & CFO) Option Ex 1,500 .00 0
2023-02-16 Rubin Jonathan (SVP, Chief Medical Officer) Option Ex 1,500 .00 0
2023-02-16 Mottola Frank (SVP, Quality, GMP, Ops, IT) Option Ex 1,500 .00 0
2023-02-16 Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) Option Ex 1,500 .00 0
2023-02-03 Khattar Jack A. (President, CEO) Sale 200 42.02 8,404
2023-02-03 Khattar Jack A. (President, CEO) Option Ex 330 9.56 3,154
2023-02-02 Khattar Jack A. (President, CEO) Sale 13,532 42.05 569,088
2023-02-02 Khattar Jack A. (President, CEO) Option Ex 22,515 9.56 215,243
2023-02-01 Khattar Jack A. (President, CEO) Sale 300 42.01 12,602
2023-02-01 Khattar Jack A. (President, CEO) Option Ex 498 9.56 4,760
2023-01-31 Khattar Jack A. (President, CEO) Sale 976 42.01 41,002
2023-01-31 Khattar Jack A. (President, CEO) Option Ex 1,620 9.56 15,487
2023-01-18 Khattar Jack A. (President, CEO) Sale 4,936 40.40 199,394
2023-01-18 Khattar Jack A. (President, CEO) Option Ex 8,080 9.56 77,244
2023-01-10 Hudson Frederick M. Option Ex 8,722 7.90 68,903
2022-12-28 Newhall Charles W Iii Option Ex 8,722 7.90 68,903
2022-11-25 Khattar Jack A. (President, CEO) Sale 11,135 35.18 391,684
2022-11-25 Khattar Jack A. (President, CEO) Option Ex 17,794 9.56 170,110
2022-11-23 Khattar Jack A. (President, CEO) Sale 2,259 35.05 79,189
2022-11-23 Khattar Jack A. (President, CEO) Option Ex 3,616 9.56 34,568
2022-11-22 Khattar Jack A. (President, CEO) Sale 1,200 35.00 42,002
2022-11-22 Khattar Jack A. (President, CEO) Option Ex 1,918 9.56 18,336
2022-11-15 Khattar Jack A. (President, CEO) Sale 2,230 35.00 78,056
2022-11-15 Khattar Jack A. (President, CEO) Option Ex 3,566 9.56 34,090
2022-11-09 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Sale 700 34.97 24,479
2022-11-09 Bhatt Padmanabh P. (Sr. VP of IP, CSO) Option Ex 700 9.24 6,468
2022-09-14 Khattar Jack A. (President, CEO) Option Ex 7,275 16.88 122,765
2022-08-16 Khattar Jack A. (President, CEO) Sale 14,690 34.01 499,650
2022-08-16 Khattar Jack A. (President, CEO) Option Ex 48,712 17.01 828,444
2022-08-15 Khattar Jack A. (President, CEO) Sale 17,302 34.03 588,752
2022-08-15 Khattar Jack A. (President, CEO) Option Ex 57,388 17.01 976,399
2022-08-10 Khattar Jack A. (President, CEO) Sale 28,437 31.22 887,803
2022-08-10 Khattar Jack A. (President, CEO) Option Ex 44,900 .00 0
2022-08-09 Khattar Jack A. (President, CEO) Sale 39,431 31.15 1,228,275
2022-08-09 Khattar Jack A. (President, CEO) Option Ex 63,100 .00 0
2022-08-04 Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) Sale 5,000 32.98 164,899
2022-08-04 Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) Option Ex 5,000 7.90 39,500
2021-08-11 Siebert John M Option Ex 15,000 12.98 194,700
2021-04-14 Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) Sale 3,125 31.98 99,937
2021-04-14 Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) Option Ex 3,125 12.98 40,562
2021-04-13 Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) Sale 3,125 29.98 93,703
2021-04-13 Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) Option Ex 3,125 12.98 40,562
2020-12-21 Schwabe Stefan K.f. (Executive Vice President & CMO) Sale 46,347 22.10 1,024,454
2020-12-21 Schwabe Stefan K.f. (Executive Vice President & CMO) Option Ex 46,347 12.98 601,584
2020-12-14 Schwabe Stefan K.f. (Executive Vice President & CMO) Sale 53,653 21.93 1,176,556
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of SUPN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Supernus Pharmaceuticals, Inc. (symbol SUPN, CIK number 1356576) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.